Search


Current filters:

Clear current filters  or Add more filters

View Option



Results 31-40 of 81 (Search time: 0.004 seconds).

  The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia (Journal article)

  THE EFFECTS OF COMBINING ROSUVASTATIN WITH SARTANS OF DIFFERENT PPAR gamma ACTIVATING CAPACITY ON LOW-DENSITY LIPOPROTEIN SUBFRACTIONS AND LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A(2) (Journal article)

  The Effects of Hypolipidemic Regimen on Low Density Lipoprotein (Ldl) Phenotype in Patients with Mixed Hyperlipidemia (Journal article)

  The influence of serum apolipoprotein E concentration and polymorphism on serum lipid parameters in hemodialysis patients (Journal article)

  Effect of Ezetimibe on Markers of Oxidative Stress in Patients with Hypercholesterolemia (Journal article)

  Dose-dependent Effect of Rosuvastatin Treatment on HDL-subfraction Phenotype in Patients With Primary Hyperlipidemia (Journal article)

  Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed Dyslipidaemia (Journal article)

  Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect (Journal article)

  Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin (Journal article)

  Plasma Visfatin Concentration Is a Marker of an Atherogenic Metabolic Profile (Journal article)